logo

For the Inventor, By the Inventor

Munich, Germany

Wilex Ag


USPTO Granted Patents = 36



Forward Citations = 183

Loading Chart...
Loading Chart...

51 inventors (with patents filed for the assignee):

goldMedal Olaf G Wilhelm (11 out of 15 patents)

silverMedal Viktor Magdolen (8 out of 12 patents)

bronzeMedal Stefan Sperl (8 out of 10 patents)

4.  Manfred Schmitt (5 out of 15 patents)

5.  Hugo Ziegler (5 out of 39 patents)

6.  Peter Wikstroem (5 out of 13 patents)

7.  Horst Kessler (4 out of 34 patents)

8.  Sven Warnaar (4 out of 4 patents)

9.  Wolfgang Schmalix (4 out of 4 patents)

10.  Jörg Stürzebecher (4 out of 7 patents)

11.  Markus Buergle (4 out of 4 patents)

12.  Stefan Ullrich (3 out of 7 patents)

13.  Markus Bürgle (3 out of 3 patents)

14.  Luis Moroder (3 out of 12 patents)

15.  Thomas Luther (3 out of 3 patents)


36 patents:

1. 10620208 - Classifying a cancer disease using CAIX expression (2020-04-14),
2. RE46424 - Method for producing 3-amidinophenylalanine derivatives (2017-06-05),
3. 9605075 - Hybridoma cell line G250 and its use for producing monoclonal antibodies (2017-03-28),
4. 9089532 - Stable dosage form of phenylalanine derivatives (2015-07-28),
5. 8828381 - Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas (2014-09-09),
6. 8642761 - Method for producing 3-amidinophenylalanine derivatives (2014-02-04),
7. 8492520 - Binding epitopes for G250 antibody (2013-07-23),
8. 8492385 - Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof (2013-07-23),
9. 8461321 - Nucleic acids encoding a deletion variant of uPAR (2013-06-11),
10. 8093258 - Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases (2012-01-10),
11. 8088921 - Method for producing 3-amidinophenylalanine derivatives (2012-01-03),
12. 7951943 - Method for preparing and purifying 3-hydroxyamidinophenylalanine compounds (2011-05-31),
13. 7951589 - Monoclonal antibodies specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor (2011-05-31),
14. 7884206 - Method for producing 3-amidinophenylalanine derivatives (2011-02-08),
15. 7807681 - Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors (2010-10-05),
Wilex AG is a biopharmaceutical company focused on the development and commercialization of innovative cancer therapeutics. With a strong portfolio of drug candidates and expertise in oncology, we aim to provide effective treatment options for patients in need. Our wide range of products includes targeted antibodies, small molecules, and antibody-drug conjugates, all designed to tackle various forms of cancer. Visit our website to learn more about our mission, pipeline, and ongoing research projects.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

36 Patents

#86 in W-8000 Munich

#1,417 in Germany

#18,179 in the World

...
Munich, Germany

Wilex Ag

Forward Citations = 183

51 inventors:

goldMedal Olaf G Wilhelm (11 out of 15 patents)

silverMedal Viktor Magdolen (8 out of 12 patents)

bronzeMedal Stefan Sperl (8 out of 10 patents)

4.  Manfred Schmitt (5 out of 15 patents)

5.  Hugo Ziegler (5 out of 39 patents)

Please report any incorrect information to support@idiyas.com
Loading…